3 completed, 1 unknown. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Meibomitis: new trials by email Literature Review of Meibomitis trials Research Report on Meibomitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Maskin Probe - Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses | Not applicable | Unknown | Massachusetts Eye and Ear Infirmary | 30 | 2021-12-01 | 2021-12-06 |
| Effect of HMG-CoA Reductase Inhibitors on the Meibomian Gland Morphology in Patients With Meibomitis Keratograph 5M, Oculus, Wetzlar, Germany - Meibomian Gland Dysfunction, Meibomitis | Completed | National Taiwan University Hospital | 98 | 2016-12-08 | 2020-10-14 | |
| Treatment of Patients With Blepharitis and Facial Rosacea COL-101 (doxycycline, USP) capsules, placebo - Blepharitis, Meibomianitis | Phase 2 | Completed | Galderma R&D | 70 | 2007-11-01 | 2021-02-18 |
| Evaluation and Treatment of Patients With Corneal and External Diseases Blepharitis, Conjunctivitis | Completed | National Eye Institute (NEI) | 600 | 2001-01-02 | 2017-07-02 |
Blepharitis (2) · Dry Eye Syndromes (2) · Meibomian Gland Dysfunction (2) · Conjunctivitis (1) · Corneal Diseases (1) · Dacryocystitis (1) · Dyslipidemias (1) · Keratitis (1) · Stevens-Johnson Syndrome (1)
Eye Diseases (4) · Eyelid Diseases (4) · Lacrimal Apparatus Diseases (3) · Blepharitis (2) · Chemically-Induced Disorders (1) · Conjunctival Diseases (1) · Dermatitis (1) · Drug Eruptions (1) · Drug Hypersensitivity (1) · Drug-Related Side Effects and Adverse Reactions (1) · Erythema (1) · Erythema Multiforme (1) · Hypersensitivity (1) · Hypersensitivity, Delayed (1) · Immune System Diseases (1)
Capsules (1) · Doxycycline (1)
Galderma R&D (1) · Massachusetts Eye and Ear Infirmary (1) · National Eye Institute (NEI) (1) · National Taiwan University Hospital (1)
United States (3) · Taiwan (1)
I-Jong Wang, MD,PhD (1) · Michael Graeber, MD (1)